{"id":"https://openalex.org/W4361849093","doi":"https://doi.org/10.1158/0008-5472.22418646","title":"Supplemental Figures from An HK2 Antisense Oligonucleotide Induces Synthetic Lethality in HK1\u2212HK2+ Multiple Myeloma","display_name":"Supplemental Figures from An HK2 Antisense Oligonucleotide Induces Synthetic Lethality in HK1\u2212HK2+ Multiple Myeloma","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361849093","doi":"https://doi.org/10.1158/0008-5472.22418646"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.22418646","doi":"https://doi.org/10.1158/0008-5472.22418646","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.22418646","pdf_url":"https://aacr.figshare.com/ndownloader/files/39864771","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://aacr.figshare.com/ndownloader/files/39864771","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5034539983","display_name":"Shili Xu","orcid":"https://orcid.org/0000-0002-4933-8673","observed_orcids":["https://orcid.org/0000-0002-4933-8673"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shili Xu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101996417","display_name":"Tianyuan Zhou","orcid":"https://orcid.org/0000-0002-5496-4839","observed_orcids":["https://orcid.org/0000-0002-5496-4839"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tianyuan Zhou","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009344174","display_name":"Hanna M. Doh","orcid":"https://orcid.org/0000-0003-0781-611X","observed_orcids":["https://orcid.org/0000-0003-0781-611X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hanna M. Doh","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047681573","display_name":"K Ryan Trinh","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K Ryan Trinh","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036437386","display_name":"Art Catapang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Art Catapang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061350746","display_name":"Jason T. Lee","orcid":"https://orcid.org/0000-0003-2590-2011","observed_orcids":["https://orcid.org/0000-0003-2590-2011"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jason T. Lee","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035146434","display_name":"Daniel Braas","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daniel Braas","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060762596","display_name":"Nicholas A. Bayley","orcid":"https://orcid.org/0000-0003-0489-0592","observed_orcids":["https://orcid.org/0000-0003-0489-0592"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nicholas A. Bayley","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018823792","display_name":"Reiko E. Yamada","orcid":"https://orcid.org/0000-0002-2680-6972","observed_orcids":["https://orcid.org/0000-0002-2680-6972"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Reiko E. Yamada","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-2680-6972","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005160594","display_name":"Alex Vasuthasawat","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alex Vasuthasawat","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007397397","display_name":"Joshua P. Sasine","orcid":"https://orcid.org/0000-0001-9866-462X","observed_orcids":["https://orcid.org/0000-0001-9866-462X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joshua P. Sasine","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9866-462X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107833759","display_name":"John M. Timmerman","orcid":"https://orcid.org/0000-0003-4104-8943","observed_orcids":["https://orcid.org/0000-0003-4104-8943"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John M. Timmerman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041161932","display_name":"Sarah Marie Larson","orcid":"https://orcid.org/0000-0002-4335-2925","observed_orcids":["https://orcid.org/0000-0002-4335-2925"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sarah M. Larson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100713154","display_name":"Young Soo Kim","orcid":"https://orcid.org/0000-0001-5029-7082","observed_orcids":["https://orcid.org/0000-0001-5029-7082"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Youngsoo Kim","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103250386","display_name":"A. Robert MacLeod","orcid":"https://orcid.org/0000-0002-8092-1840","observed_orcids":["https://orcid.org/0000-0002-8092-1840"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. Robert MacLeod","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113503188","display_name":"Sherie Leaver Morrison","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sherie L. Morrison","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5111588120","display_name":"Harvey R. Herschman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Harvey R. Herschman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.8817999958992004,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.8817999958992004,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10631","display_name":"Cancer, Hypoxia, and Metabolism","score":0.09189999848604202,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.8619999885559082},{"id":"https://openalex.org/keywords/synthetic-lethality","display_name":"synthetic lethality","score":0.8820000290870667},{"id":"https://openalex.org/keywords/dichloroacetate","display_name":"dichloroacetate","score":0.7179999947547913},{"id":"https://openalex.org/keywords/phenformin","display_name":"phenformin","score":0.46799999475479126},{"id":"https://openalex.org/keywords/perifosine","display_name":"perifosine","score":0.4169999957084656},{"id":"https://openalex.org/keywords/met","display_name":"MET","score":0.33799999952316284},{"id":"https://openalex.org/keywords/tca-cycle-metabolites","display_name":"TCA cycle metabolites","score":0.8519999980926514},{"id":"https://openalex.org/keywords/amino-acids","display_name":"amino acids","score":0.6290000081062317},{"id":"https://openalex.org/keywords/purines-and-pyrimidines","display_name":"purines and pyrimidines","score":0.9350000023841858},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.4860000014305115}],"concepts":[{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.6084063649177551},{"id":"https://openalex.org/C169586020","wikidata":"https://www.wikidata.org/wiki/Q3780159","display_name":"Purine metabolism","level":3,"score":0.5045205354690552},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.481594055891037},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4620164632797241},{"id":"https://openalex.org/C2778502085","wikidata":"https://www.wikidata.org/wiki/Q7662767","display_name":"Synthetic lethality","level":4,"score":0.437033087015152},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.40221095085144043},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.38614344596862793},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3435227870941162},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.2790018916130066},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2742110788822174},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.15106606483459473},{"id":"https://openalex.org/C134935766","wikidata":"https://www.wikidata.org/wiki/Q210538","display_name":"DNA repair","level":3,"score":0.13379472494125366},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1158/0008-5472.22418646","doi":"https://doi.org/10.1158/0008-5472.22418646","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.22418646","pdf_url":"https://aacr.figshare.com/ndownloader/files/39864771","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/0008-5472.22418646.v1","doi":"https://doi.org/10.1158/0008-5472.22418646.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.22418646.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22418646","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplemental_Figures_from_An_HK2_Antisense_Oligonucleotide_Induces_Synthetic_Lethality_in_HK1_sup_sup_HK2_sup_sup_Multiple_Myeloma/22418646","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/0008-5472.22418646","doi":"https://doi.org/10.1158/0008-5472.22418646","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.22418646","pdf_url":"https://aacr.figshare.com/ndownloader/files/39864771","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4361849093.pdf","grobid_xml":"https://content.openalex.org/works/W4361849093.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2922280173","https://openalex.org/W4361849269","https://openalex.org/W4391643184","https://openalex.org/W6977186705","https://openalex.org/W4407857128","https://openalex.org/W4200167056","https://openalex.org/W7106313750","https://openalex.org/W2028073021","https://openalex.org/W7223131433","https://openalex.org/W2765905503"],"abstract_inverted_index":{"This":[0],"file":[1],"contains":[2],"supplemental":[3],"figures:":[4],"Supplemental":[5,18,30,45,57,94,129],"Figure":[6,19,31,46,58,95,130],"S1.":[7],"HK2":[8,140],"ASOs":[9],"selectively":[10],"inhibit":[11],"the":[12],"proliferation":[13],"of":[14,36,61,65,82,98,102,120,138],"HK1-HK2+":[15,28,66,103],"MM":[16,41,162],"cells.":[17,29,163],"S2.":[20],"The":[21],"HK2-ASO1/DPI/PER":[22],"combination":[23,148],"causes":[24],"synthetic":[25],"lethality":[26],"in":[27,77,114,135,147,154],"3.":[32],"In":[33,132],"vivo":[34,136],"effects":[35,137],"HK2-ASO1,":[37,70,107],"DPI,":[38,71,108,150],"PER":[39,153],"on":[40,79,116],"OPM2":[42,67,104],"xenograft":[43],"models.":[44],"4.":[47],"MET":[48,72,109],"can":[49],"replace":[50],"DPI":[51],"for":[52],"mitochondrial":[53],"oxidative":[54],"phosphorylation":[55],"inhibition.":[56],"S5.":[59],"Effects":[60],"24":[62,99],"h":[63,100],"treatments":[64,101],"cells":[68,105],"with":[69,106,149],"and":[73,76,92,110,113,127,134,146,152,158],"PER,":[74,111],"alone":[75,112],"combination,":[78,115],"relative":[80,117],"amounts":[81],"amino":[83,124],"acids,":[84,125],"TCA":[85,121],"cycle":[86,122],"metabolites,":[87,123],"fatty":[88],"acid":[89],"intermediates,":[90],"purines":[91],"pyrimidines.":[93,128],"S6.":[96],"Effect":[97],"13C-labeled":[118],"portions":[119],"purines,":[126],"S7.":[131],"vitro":[133],"mouse":[139,155],"(mHK2)":[141],"ASOs,":[142],"as":[143],"single":[144],"agents":[145],"MET,":[151],"P3":[156,159],"(HK1-HK2+)":[157],"(HK1+HK2+)":[160],"isogenic":[161]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-04-05T00:00:00"}